Predicting the development of diabetic nephropathy and its progression

Advances in Chronic Kidney Disease

Volumn 12, Issue 2, 2005, Pages 202-211

  William, Josette ^a   Hogan, Donn ^a   Batlle, Daniel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ACE gene polymorphisms; ACE inhibitors; Diabetic nephropathy; Nocturnal Hypertension; Proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALLELE; CLINICAL FEATURE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FAMILY HISTORY; FOLLOW UP; GENETIC MARKER; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 16844362706     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2005.02.001     Document Type: Article

References (76)

1. A. Amos, D. McCarthy, P. Zimmet The rising global burden of diabetes and its complications Estimates and projections to the year 2010 Diabetes Med 14 Suppl 5 1997 S1 S85 (suppl 5)
2. H. King, R. Aubert, W. Herman Global burden of diabetes 1995-2025. Prevalence, numerical estimates and projections Diabetes Care 21 1998 1414 1431
3. D. Batlle Clinical and cellular markers of diabetic nephropathy Kidney Int 63 2003 2319 2330
4. A. Mogyorosi, F.N. Ziyadeh Update on pathogenesis, markers and management of diabetic nephropathy Curr Opin Nephrol Hypertens 5 1996 243 253
5. K.M.L.S.T. Moorthi, E. Lurbe, J. Redon Nocturnal hypertension Is it important to control nighttime blood pressure to prevent progression of diabetic renal disease? Hypertension Rep 6 2004 393 399
6. W.F. Keane, B.M. Brenner, D. DeZeeuw The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy The RENAAL study Kidney Int 36 2003 1499 1507
7. H.H. Parving Diabetic nephropathy Prevention and treatment Kidney Int 60 2001 2041 2055
8. G. Remuzzi, P. Ruggenenti, N. Perico Chronic renal diseases Renal protective benefits of renin-angiotensin system inhibition Ann Intern Med 136 2002 604 615
9. D. DeZeeuw, G. Remuzzi, H.H. Parving Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy Lessons from RENAAL Kidney International Kidney Int 65 2004 2309 2320
10. G. Remuzzi, T. Bertani Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38 1990 384 394
11. E.J. Lewis, L.G. Hunsicker, R.P. Bain The effect of angiotensin- converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
12. G. Maschio, D. Alberti, G. Janin Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
13. J.A. Breyer, P. Bain, J.K. Evans Predictors of the progression of renal insufficiency in patients with insulin dependent diabetes and over diabetic nephropathy Kidney Int 50 1996 1651 1658
14. P. Rossing, E. Hommel, U.M. Smidt Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment Diabetologia 37 1994 511 516
15. P. Fioretto, M.W. Steffes, J. Barbosa Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs Diabetes 48 1999 865 869
16. M. Quinn, M.C. Angelico, J.H. Warram Familial factors determine the development of diabetic nephropathy in patients with IDDM Diabetologia 39 1996 940 945
17. E.R. Seaquist, F.C. Goetz, S. Rich Familial clustering of diabetic kidney disease N Engl J Med 320 1989 1161 1165
18. The Diabetes Control and Complications Trial Research Group Clustering of long term complications in families with diabetes in the diabetes control and complications trials Diabetes 46 1997 1829 1839
19. K. Borch-Johnsen, K. Norgaard, E. Hommel Is diabetic nephropathy an inherited complication? Kidney Int 41 1992 719 722
20. A.S. Krolewski, M. Canessa, J.A. Warram Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus N Engl J Med 1988 1988 140 145
21. G.C. Viberti, H. Keen, M.J. Wiseman Raised arterial pressure in parents of proteinuric insulin dependent diabetes Br J Med 295 1987 515 517
22. J. Brazilay, J.H. Warram, M. Bak Predisposition to hypertension Risk factors for nephropathy and hypertension in IDDM Kidney Int 41 1992 723 730
23. K. Earle, G.C. Viberti, J. Walker Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy N Engl J Med 326 1992 673 677
24. J. Yip, M.B. Mattock, A. Morocutti Insulin resistance in insulin-dependent diabetic patients with MA Lancet 342 1993 883 887
25. C.E. Mogensen, C.K. Christensen Predicting diabetes in insulin-dependent patients N Engl J Med 311 1984 89 93
26. H.H. Parving, B. Oxenboll, J. Tacons Early detection of patients at risk of developing diabetic nephropathy A longitudinal study of urinary albumin excretion Acta Endocrinol 100 1982 550 555
27. G.C. Viberti, R.D. Hill, R.J. Jarrett Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus Lancet 1 1982 1430 1432
28. H.J. Bangstand, R. Osterby, K. Dahl-Jorgensen Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with MA Diabetologia 36 1993 523 529
29. B.M. Chavers, R.W. Bilous, E.N. Ellis Glomerular lesions and urinary albumin excretion in type 1 diabetic patients without overt proteinuria N Engl J Med 320 1989 966 970
30. P. Fioretto, M.W. Steffes, M. Mauer Glomerular structure in nonproteinuric insulin-dependent diabetic patients with various levels of albuminuria Diabetes 43 1994 1358 1364
31. M.L. Caramori, P. Fioretto, M. Mauer The need for early predictors of diabetic nephropathy risk Is albumin excretion rate sufficient? Diabetes 49 2000 1399 1408
32. S.C. Bain, T.A. Chowdhury Genetics of diabetic nephropathy and microalbuminuria J R Soc Med 93 2000 62 66
33. P.W. de Leeuw, S.J. van Leeuwen, W.H. Birkenhanger Effect of sleep on blood pressure and correlates Clin Exp Hypertens 7 1985 179 186
34. C.M. Forsblom, P.H. Groop, A. Ekstrand Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration Br J Med 305 1992 1051 1053
35. S. Rundberg, B. Persson, G. Dahlquist Increased glomerular filtration rate as a predictor of diabetic nephropathy Kidney Int 41 1992 822 828
36. The Diabetes Control and Complications Trial Research Group Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial Kidney Int 47 1995 1703 1720
37. The ACE Inhibitors IN Diabetic Nephropathy Trialist Group Should all type 1 diabetic microalbuminuric patients receive ACE inhibitors? A meta-regression analysis Ann Intern Med 134 2001 370 379
38. E.R. Mathiesen, E. Hommel, H.P. Hansen Randomized controlled trial of long term efficacy of captopril and preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria Circulation 319 1999 24 25
39. E. Lurbe, J. Redon, A. Kesani Increase in nocturnal blood pressure and progresssion to microalbuminuria in type 1 diabetes N Engl J Med 347 2002 797 805
40. MA Collaborative Study Group Predictors of the development of MA in patients with type 1 diabetes mellitus A 7 year prospective study Diabetes Med 16 1991 918 925
41. P.L. Poulsen, E. Ebbehoj, K.W. Hansen 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients Diabetologia 40 1997 718 725
42. K. Norgaard, B. Feldt-Rasmussen, K. Borch-Johnsen Prevalance of hypertension in type 1 (insulin dependent) diabetes mellitus Diabetologia 33 1990 407 410
43. H.P. Hansen, P. Rossing, L. Tarnow Circadian rhythm of arterial pressure and albuminuria in diabetic nephropathy Kidney Int 50 1996 579 585
44. A.R. Lafferty, G.A. Werther, C.F. Clarke Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type I diabetes Diabetes Care 23 2000 989 993
45. A. Lurbe, J. Redon, J.M. Pascual Altered blood pressure during sleep in normotensive subjects with type I diabetes Hypertension 21 1993 227 235
46. W.V. Moore, D.L. Donaldson, A.M. Chonko Ambulatory blood pressure in type I diabetes mellitus comparison to presence of incipient nephropathy in adolescents and young adults Diabetes 41 1992 1035 1041
47. M. Pecis, M.J. Azevedo, R.S. Moraes Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type I diabetic patients Diabetes Care 23 2000 989 993
48. V. Spallone, S. Gambardella, M. Maiello Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients Diabetes Care 17 1994 578 584
49. P. Voros, Z. Lengyel, V. Nagy Diurnal blood pressure variation and albuminuria in normotensive patients with insulin-dependent diabetes mellitus Nephrol Dial Transplant 13 1998 2257 2260
50. C. Farmer, D. Goldsmith, D. Quin Progression of diabetic nephropathy--Iis diurnal blood pressure rhythm as important as absolute blood pressure level? Nephrol Dial Transplant 13 1998 635 639
51. F.S. Nielsen, P. Rossing, L.E. Bang On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy Diabetes 44 1995 783 789
52. P. Palatini, M. Penzo, A. Racioppa Clinical relevance of nighttime blood pressure and of daytime blood pressure variability Arch Intern Med 152 1992 1855 1860
53. P. Verdecchia, G. Schillaci, M. Guerrieri Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension Circulation 81 1990 528 536
54. D. Hogan, A. Lurbe, R. Salabat Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients Current Diabetes Rep 2 2002 539 544
55. N. Chaturvedi, A. Sjolie, J. Stevenson Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes Lancet 351 1993 1456 1462
56. S. Fava, J. Azzopardi, S. Ellard ACE gene polymorphism as a prognostic indicator in renal patients with type 2 diabetes and established renal disease Diabetes Care 24 2001 2115 2120
57. S. Bjorck, G. Blohme, C. Sylven Deletion/insertion polymorphism of the ACE gene and progression of diabetic nephropathy Nephrol Dial Transplant 12 1997 67 70
58. T. Fujisawa, H. Ikegami, Y. Kawaguchi Meta-analysis of association of insertion/deletion polymorphism of angiotensin-I-converting enzyme gene with diabetic nephropathy and retinopathy Diabetologia 41 1998 47 53
59. T. Wong, J. Chan, E. Poon Lack of association of angiotensin-I-converting enzyme (DD/II) and angiotensinogen M235 T gene polymorphism with renal function among Chinese patients with type 2 diabetes Am J Kidney Dis 33 1999 1064 1070
60. H. Yoshida, V. Kon, I. Ichikawa Polymorphisms of the renin-angiotensin system genes in progressive renal diseases Kidney Int 50 1996 732 744
61. S. Schmidt, K. Strojek, W. Grzeszczak Excess of DD homozygotes patients in type II diabetes Nephrol Dial Transplant 12 1997 427 429
62. H.H. Parving, P. Jacobsen, L. Tarnow Effect of deletion polymorphism of angiotensin-converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin-converting enzyme Observational follow up study BMJ 313 1996 591 594
63. M. Marre, X. Jeunemaitre, Y. Gallois Contribution of genetic polymorphism in the renin- angiotensin system to the development of renal complications in insulin dependent diabetes J Clin Invest 99 1997 1585 1595
64. H. Arzu Ergen, H. Hatemi, B. Agachan Angiotensin-I-converting enzyme gene polymorphism Turkish type 2 diabetic patients Exp Mol Med 36 2004 345 350
65. P. Jacobsen, L. Tarnow, B. Carstensen Genetic variation in the renin angiotensin system and progression of diabetic nephropathy J Am Soc Nephrol 14 2003 2843 2850
66. S. Cosmo, G. Miscio, L. Zucaro The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients Evidence for a polygenic control of kidney disease progression Nephrol Dial Transplant 17 2002 1402 1407
67. S. Hadjadj, R. Belloum, B. Bouhanick Prognostic value of angiotensin I-converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus A prospective study J Am Soc Nephrol 12 2001 541-519
68. F. Ittersum, A. Man, S. Tyssen Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus Nephrol Dialy Transplant 15 2000 1000 1007
69. L. Tarnow, C. Gluud, H.H. Parving Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-I-converting enzyme gene Nephrol Dial Transplant 13 1998 1125 1130
70. E. Kajantie, A. Rautanen, J. Kere The effects of the ACE gene insertion/deletion polymorphism on glucose tolerance and insulin secretion in elderly people are modified by birth weight J Clin Endocrinol Metab 111 2004 5738 5741
71. B. Rigat, C. Hubert, F. Alhenc-Gelas An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 86 1990 1343 1346
72. M. Pueyo, M. Ghallah, D. Gauguier Transforming growth factor-B1 production is correlated with genetically determined ACE expression in congenic rats Diabetes 53 2004 1111 1118
73. M. Ye, J. Wysocki, P. Naaz Increased ACE2 and decreased ACE protein in renal tubules from diabetic mice A renoprotective combination? Hypertension 43 2004 1120 1125
74. A. Solini, M. Vestra, A. Saller The angiotensin-I-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes Diabetes 51 2002 251 255
75. L. Tarnow, F. Cambien, P. Rossing Lack of relationship between insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients Diabetes 44 1995 489 494
76. G. Penno, N. Chaturvedi, P. Talmud Effect of angiotensin converting enzyme gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients Finds from the EUCLID randomized controlled trial Diabetes 41 1998 1507 1511